Pub. Date : 2010 Mar
PMID : 19786087
9 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Induction of apoptosis by esculetin in human leukemia U937 cells: roles of Bcl-2 and extracellular-regulated kinase signaling. | esculetin | BCL2 apoptosis regulator | Homo sapiens |
2 | In the present study, we reported that apoptosis induced by esculetin, a phenolic compound with apoptotic activity in cancer cells, was markedly blocked by Bcl-2-overexpression, but restored by HA14-1, a small-molecule Bcl-2 inhibitor, in human leukemic U937 cells. | esculetin | BCL2 apoptosis regulator | Homo sapiens |
3 | In the present study, we reported that apoptosis induced by esculetin, a phenolic compound with apoptotic activity in cancer cells, was markedly blocked by Bcl-2-overexpression, but restored by HA14-1, a small-molecule Bcl-2 inhibitor, in human leukemic U937 cells. | esculetin | BCL2 apoptosis regulator | Homo sapiens |
4 | The combined use of esculetin and HA14-1 effectively induced Bid cleavage and loss of mitochondrial membrane potential (MMP, Deltapsi(m)) leading to the activation of caspases and cleavage of poly(ADP-ribose) polymerase (PARP) in Bcl-2-overexpressing (U937/Bcl-2) cells. | esculetin | BCL2 apoptosis regulator | Homo sapiens |
5 | The combined use of esculetin and HA14-1 effectively induced Bid cleavage and loss of mitochondrial membrane potential (MMP, Deltapsi(m)) leading to the activation of caspases and cleavage of poly(ADP-ribose) polymerase (PARP) in Bcl-2-overexpressing (U937/Bcl-2) cells. | esculetin | BCL2 apoptosis regulator | Homo sapiens |
6 | The results indicate that HA14-1-induced reversal of the anti-apoptotic effect of Bcl-2 confers apoptosis sensitivity to esculetin by a mitochondrial amplification step and through the ERK-dependent induction of DR4 expression in U937/Bcl-2 cells. | esculetin | BCL2 apoptosis regulator | Homo sapiens |
7 | Thus, HA14-1 reversal of Bcl-2-mediated esculetin resistance suggests a novel strategy for increasing esculetin sensitivity in Bcl-2-overexpressing leukemia cells. | esculetin | BCL2 apoptosis regulator | Homo sapiens |
8 | Thus, HA14-1 reversal of Bcl-2-mediated esculetin resistance suggests a novel strategy for increasing esculetin sensitivity in Bcl-2-overexpressing leukemia cells. | esculetin | BCL2 apoptosis regulator | Homo sapiens |
9 | Thus, HA14-1 reversal of Bcl-2-mediated esculetin resistance suggests a novel strategy for increasing esculetin sensitivity in Bcl-2-overexpressing leukemia cells. | esculetin | BCL2 apoptosis regulator | Homo sapiens |